ADAPTIVE
Live / Registered — Registered (as of 06 Dec 2022)
What this means for you
Registered since 06 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90459478
- Registration number
- 6919051
- Mark type
- Word mark
- Filed
- 11 Jan 2021
- Published for opposition
- 07 Sept 2021
- Registered
- 06 Dec 2022
- Attorney of record
- Hoang-chi Truong
Goods and services
- Class 042 — Scientific and technological services: Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; development of new technology for others in the field of immunotherapy; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services
- Class 044 — Medical, beauty and agricultural services: Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of person
Owner
- Adaptive Biotechnologies Corporation, Seattle, WA, US
- Adaptive Biotechnologies Corporation, Seattle, WA, US
- Adaptive Biotechnologies Corp., Seattle, WA, US
Prosecution history
- 06 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 29 Oct 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 28 Oct 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Oct 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Oct 2022 — USE AMENDMENT FILED
- 26 Oct 2022 — SOU EXTENSION 2 GRANTED
- 17 Oct 2022 — SOU EXTENSION 2 FILED
- 26 Oct 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 17 Oct 2022 — TEAS STATEMENT OF USE RECEIVED
- 04 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2022 — SOU EXTENSION 1 GRANTED
- 02 May 2022 — SOU EXTENSION 1 FILED